Compass Therapeutics
IPODeveloping next generation antibodies into transformative cancer therapies
Public · Cambridge, United States · Founded 2014 · $332.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- compasstherapeutics.com
- Total Funding
- $332.0M
- Last Round
- $120.0M Venture RoundAug 2025
- Rounds
- 3
- Type
- Public
About
Compass Therapeutics is a clinical-stage oncology biopharmaceutical company developing proprietary antibody-based therapeutics that target the tumor microenvironment. Their platforms enable rapid identification of therapeutic leads bridging the innate and adaptive immune system, with candidates designed to optimize critical components of anti-tumor immune responses. The company trades on Nasdaq under the ticker CMPX.
Summary
Compass Therapeutics is a Biotech company based in Cambridge, United States, founded in 2014. It has raised $332.0M in total across 3 rounds, most recently a $120.0M Venture Round round in Aug 2025. Investors include OrbiMed, F-Prime Capital and Alumni Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...